Valhi (VHI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting of Stockholders scheduled for May 22, 2025, at Dallas, Texas, to address key corporate matters.
Proxy materials, including the 2024 Annual Report and Proxy Statement, are available online for review and voting.
Stockholders are encouraged to review materials and vote electronically or request paper copies if needed.
Voting matters and shareholder proposals
Election of seven director nominees is on the agenda for shareholder approval.
Nonbinding advisory vote on named executive officer compensation will be held.
Proxies may vote on other business that arises during the meeting or any adjournment.
Board recommends voting FOR all director nominees and FOR the executive compensation proposal.
Board of directors and corporate governance
Seven individuals are nominated for election to the board, including Thomas E. Barry, Loretta J. Feehan, Terri L. Herrington, W. Hayden McIlroy, Gina A. Norris, Michael S. Simmons, and Mary A. Tidlund.
Latest events from Valhi
- Net loss in 2025 driven by weak Chemicals results, lower TiO2 prices, and higher costs.VHI
Q4 202510 Mar 2026 - Dixie Rice's majority stake ensures approval of all board and compensation proposals.VHI
Proxy Filing2 Dec 2025 - Q3 2025 net loss of $22.2M driven by Chemicals segment decline and higher tax expense.VHI
Q3 20256 Nov 2025 - Net income dropped sharply as Chemicals weakened and interest expense increased.VHI
Q2 20257 Aug 2025 - Q3 2024 net income surged to $57.5M on Chemicals strength and LPC acquisition gains.VHI
Q3 202413 Jun 2025 - Q2 profit surged to $19.9M as Chemicals volumes rose and costs fell, despite higher interest.VHI
Q2 202413 Jun 2025 - Q1 net income surged on Chemicals growth and LPC acquisition, with a strong 2025 outlook.VHI
Q1 20256 Jun 2025 - Valhi's 2024 profit surge was fueled by Chemicals Segment strength and strategic acquisitions.VHI
Q4 20245 Jun 2025